Concept and design of a nationwide prospective feasibility/efficacy/safety study of weekly paclitaxel for patients with pathologically confirmed anaplastic thyroid cancer (ATCCJ-PTX-P2)
Crossref DOI link: https://doi.org/10.1186/s12885-015-1490-8
Published Online: 2015-06-20
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Onoda, Naoyoshi
Sugitani, Iwao
Higashiyama, Takuya
Hara, Hisato
Ito, Ken-ichi
Kammori, Makoto
Sugino, Kiminori
Suzuki, Shinichi
Toda, Kazuhisa
Yoshida, Akira
Miyauchi, Akira
License valid from 2015-06-20